First Time Loading...

GSK plc
XETRA:GS71

Watchlist Manager
GSK plc Logo
GSK plc
XETRA:GS71
Watchlist
Price: 20.11 EUR -0.35%
Updated: May 7, 2024

Wall Street
Price Targets

GS71 Price Targets Summary
GSK plc

Wall Street analysts forecast GS71 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GS71 is 22.62 EUR with a low forecast of 14.16 EUR and a high forecast of 31.27 EUR.

Lowest
Price Target
14.16 EUR
30% Downside
Average
Price Target
22.62 EUR
12% Upside
Highest
Price Target
31.27 EUR
56% Upside
GSK plc Competitors:
Price Targets
600351
Yabao Pharmaceutical Group Co Ltd
61% Upside
UCB
Ucb SA
7% Upside
LABP
Landos Biopharma Inc
41% Downside
GTII
Green Thumb Industries Inc
53% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
1% Downside
REC
Recordati Industria Chimica e Farmaceutica SpA
5% Upside
HYL
Hyloris Pharmaceuticals SA
80% Upside
TLRY
Tilray Brands Inc
18% Upside

Revenue
Forecast

Revenue Estimate
GSK plc

For the last 8 years the compound annual growth rate for GSK plc's revenue is 3%. The projected CAGR for the next 3 years is 6%.

3%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GSK plc

For the last 8 years the compound annual growth rate for GSK plc's operating income is 7%. The projected CAGR for the next 3 years is 10%.

7%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
GSK plc

For the last 8 years the compound annual growth rate for GSK plc's net income is -6%. The projected CAGR for the next 3 years is 18%.

-6%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GS71's stock price target?
Price Target
22.62 EUR

According to Wall Street analysts, the average 1-year price target for GS71 is 22.62 EUR with a low forecast of 14.16 EUR and a high forecast of 31.27 EUR.

What is GSK plc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for GSK plc's revenue is 3%. The projected CAGR for the next 3 years is 6%.

What is GSK plc's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for GSK plc's operating income is 7%. The projected CAGR for the next 3 years is 10%.

What is GSK plc's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for GSK plc's net income is -6%. The projected CAGR for the next 3 years is 18%.